SEC Form 4 · accession 0001185945-26-000004
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chris A Rallis
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 10, 2026 · 5:24 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001211583
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $8.70 | Jun 10, 2026 | A | 20,000 | A | Jun 10, 2026 | Jun 10, 2036 | Common shares | 20,000 | 200,000 | D |
Explanation of responses
- F1On June 10, 2026, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
- F2The option is 100% vested on date of grant.